Product
Atropine Sulfate
Aliases
Eye drops, Low dose atropine sulfate, Low dose atropine sulfate eye drops, Lower dose atropine sulfate, Lower dose atropine sulfate eye drops
7 clinical trials
6 indications
Indication
MyopiaIndication
ChildhoodIndication
AtropineIndication
Organophosphorus PoisoningIndication
ProgressiveClinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops in Slowing the Progression of Myopia in ChildrenStatus: Active (not recruiting), Estimated PCD: 2023-08-20
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops in Slowing the Progression of Myopia in ChildrenStatus: Active (not recruiting), Estimated PCD: 2024-08-01
Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Therapeutic Effect and Safety of LPTAT in Children With MyopiaStatus: Recruiting, Estimated PCD: 2023-06-30
Clinical trial
A Two-Period, Two-Sequence, Two-Treatment, Single-Dose Crossover Study of Atropine Sulfate Ophthalmic Solution (1%) Administered Sublingually vs Atropine Sulfate Administered Intramuscularly for Bioequivalence DeterminationStatus: Not yet recruiting, Estimated PCD: 2024-05-24
Clinical trial
Role of Intralipid in Management of Organophosphorus PoisoningStatus: Not yet recruiting, Estimated PCD: 2025-11-01
Clinical trial
A Randomized, Three-Sequence, Three-Period Crossover Study to Assess the Bioavailability and Pharmacokinetics of a Single Dose of Atropine Administered Sublingually in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2020-02-02
Clinical trial
Adverse Events Questionnaire for Low Dose Atropine Eye DropsStatus: Completed, Estimated PCD: 2023-01-09